USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Plexbio Co., Ltd.

USPTO PatentsView assignee record - 10 granted patents across 15 technology areas, active 2015–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES).

10
Total patents granted
15
CPC technology areas
22.2
Avg claims per patent
+0%
5-year filing velocity

The verdict

Plexbio holds 10 US patents across 15 technology areas, rank #27,092 of 50,000 tracked assignees.

#27,092
of 50,000 US assignees by volume
Top 38%
by Innovation Score (39.3/100)
22.2
avg claims per patent
+0%
filing velocity, last 5 yrs

Portfolio overview

Plexbio Co., Ltd. has been granted 10 US utility patents between 2015 and 2024, placing Plexbio Co., Ltd. at rank #27,092 across all assignees tracked by PlainPatent. This portfolio spans 15 distinct Cooperative Patent Classification (CPC) subclasses, averaging 22.2 claims per patent with primary concentration in G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES). As a Foreign Corporation, Plexbio Co., Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, Plexbio sits between Plastic Development Group (10 patents, rank #27,088) and Politechnika Poznanska (10 patents, rank #27,096) - the closest US assignees by grant volume. The composite Innovation Score of 39.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 5 grants, compared with 5 in the 2015–2019 window, a +0% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Plexbio Co., Ltd.'s 22.2 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 15 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Plexbio Co., Ltd. against peers pursuing similar technology classes.

Who files at Plexbio's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Plexbio holds 10 patents at rank #27,092, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Plexbio

By rank, the assignees closest to #27,092 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Plexbio's primary technology class.

Plexbio's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

39 Top 38% higher than 62% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). This entry sits in this band. 40–50: 11,491 US assignees (23%). Above this entry. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 2015201820192020202120232024 1
USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Plexbio Co., Ltd. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 1 10.0%
2018 1 10.0%
2019 3 30.0%
2020 1 10.0%
2021 1 10.0%
2023 2 20.0%
2024 1 10.0%

Which technologies does Plexbio Co., Ltd. patent most?

Top 15 of 15 technology areas

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Complex
Velocity Growing

Where it ranks

Overall rank by patents

#27,092

Across all tracked assignees

Innovation Score

39.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Plexbio Co., Ltd. hold?
Plexbio Co., Ltd. holds 10 US granted patents filed between 2015 and 2024, spanning 15 technology areas.
What is Plexbio Co., Ltd.'s Innovation Score?
Plexbio Co., Ltd. has an Innovation Score of 39.3 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Plexbio Co., Ltd. focus on?
Plexbio Co., Ltd.'s top technology area is G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES) with 9 patents. The company has filed patents in 15 CPC subclasses total.
Is Plexbio Co., Ltd.'s patent filing rate increasing or decreasing?
Plexbio Co., Ltd.'s recent filing velocity is +0% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for Plexbio Co., Ltd.'s patents?
Plexbio Co., Ltd.'s patents average 22.2 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the Plexbio Co., Ltd. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Plexbio's 10 grants land it in the top 38% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Plexbio ranks #27,092 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in G01N - see who else leads that technology area. G01N leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.